Gut Bacteria Boost Compound's Insomnia Effects in Mice
A study in mice suggests the gut microbiota help convert the compound YZG-331 into a metabolite that supports serotonin production.
Updated on Nov. 5, 2026 in Sleep Disorders
Researchers reported that YZG-331, a compound derived from the medicinal plant Gastrodia elata, improved sleep measures in mice with induced and chronic restraint-induced insomnia. The effects weakened substantially when gut microbes were depleted, pointing to a key role for the gut microbiota.
Why it matters
The findings suggest that gut bacteria may mediate how some sleep-related compounds act in the body, which could shape how future insomnia treatments are developed. The results remain preliminary and come from animal experiments.
The evidence comes from mouse experiments in which YZG-331 improved sleep measures in insomnia models and in mice receiving gut microbiota from people with insomnia. Only female mice were used and the metabolic and microbial analyses involved small samples, so the results have not been validated in males or humans.
The players
Acta Pharmaceutica Sinica B
A peer-reviewed journal in pharmaceutical sciences that published the study on YZG-331 and gut microbiota.
The details
The researchers found that gut microbes, including Lactobacillus reuteri and its enzyme RihC, convert YZG-331 into a metabolite called M2. YZG-331 and M2 raised intestinal butyric acid levels and increased metabolites involved in converting tryptophan to serotonin, a pathway linked to sleep regulation.
Timeline
Study published in Acta Pharmaceutica Sinica B, volume 16, issue 10, in 2026.
News coverage of the study appeared on November 5, 2026.
Big Picture
The study extends gut-brain axis research by showing that gut bacteria are required to convert a plant-derived sleep compound into its active form. It adds to a growing body of work suggesting microbiota can shape how neurological treatments work.
For now, this research does not change how insomnia is treated, since it has only been tested in mice. Readers interested in sleep health should continue with established approaches, and any future human trials would need to confirm whether gut-targeted compounds help people sleep.
The takeaway
Gut bacteria may influence how some sleep compounds work, so future insomnia research may need to account for the microbiome. Human studies are still needed before any practical changes to sleep care can be recommended.
Further reading
Explore more on Sleep Disorders to see how gut health and sleep research intersect.
More information
Read the full Acta Pharmaceutica Sinica B journal article on the study's DOI page.
Source note: This article includes information reported by News-Medical.
